Literature DB >> 23053963

Associations between interleukin-23 receptor polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis.

Gwan Gyu Song1, Sang-Cheol Bae, Sung Jae Choi, Jong Dae Ji, Young Ho Lee.   

Abstract

The aim of this study was to determine whether interleukin-23 receptor (IL-23R) polymorphisms confer susceptibility to rheumatoid arthritis (RA). A meta-analysis was conducted on the associations between the IL-23R rs1343151, rs10489629, rs7517847, rs11209026, rs1004819, and rs2201841 polymorphisms and RA using (1) allele contrast, (2) the recessive model, (3) the dominant model, and (4) the additive model. A total of 13 studies from eight articles involving 10,016 RA patients and 11,967 controls were considered in the meta-analysis. Meta-analysis identified a significant association between RA and the A allele of the rs1343151 polymorphism in the overall population (OR = 1.110, 95 % CI = 1.056-1.168, p = 4.7 × 10(-6)). Stratification by ethnicity identified a significant association between this polymorphism and RA in Europeans (OR = 1.105, 95 % CI = 1.049-1.163, p = 1.4 × 10(-5)). An association was also found between RA and the A allele carrier of the rs1343151 polymorphism in Europeans (OR = 1.135, 95 % CI = 1.058-1.217, p = 4.0 × 10(-5)). Meta-analysis revealed a significant association between RA and the A allele of the rs10489629 polymorphism in the overall population (OR = 1.079, 95 % CI = 1.029-1.131, p = 0.002) and in Europeans (OR = 1.092, 95 % CI = 1.038-1.149, p = 0.001). Meta-analyses of recessive, dominant, and additive models showed the same pattern as the meta-analysis of the A allele of the rs10489629 polymorphism, that is, a significant association with RA in Europeans. However, no association was found between the IL-23R rs7517847, rs11209026, rs1004819, and rs2201841 polymorphisms and RA susceptibility. This meta-analysis shows that the IL-23R rs1343151 and rs10489629 polymorphisms are associated with the development of RA in Europeans. These findings suggest that the IL-23R genes confer susceptibility to RA in the European population, but further study of this association is required in other ethnic groups.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23053963     DOI: 10.1007/s11033-012-1955-7

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  40 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

2.  Cutting edge: a variant of the IL-23R gene associated with inflammatory bowel disease induces loss of microRNA regulation and enhanced protein production.

Authors:  Antonie Zwiers; Laurens Kraal; Tineke C T M van de Pouw Kraan; Thomas Wurdinger; Gerd Bouma; Georg Kraal
Journal:  J Immunol       Date:  2012-01-18       Impact factor: 5.422

3.  The IL-23/IL-17 axis in inflammation.

Authors:  Yoichiro Iwakura; Harumichi Ishigame
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

Review 4.  Genetic progress towards the molecular basis of autoimmunity.

Authors:  Simon H S Pearce; Tony R Merriman
Journal:  Trends Mol Med       Date:  2006-01-18       Impact factor: 11.951

5.  IL-23R rs11209026 polymorphism modulates IL-17A expression in patients with rheumatoid arthritis.

Authors:  J Hazlett; L K Stamp; T Merriman; J Highton; P A Hessian
Journal:  Genes Immun       Date:  2011-12-01       Impact factor: 2.676

Review 6.  Breakthroughs in genetic studies of ankylosing spondylitis.

Authors:  M A Brown
Journal:  Rheumatology (Oxford)       Date:  2007-11-22       Impact factor: 7.580

7.  STAT4 polymorphism is associated with early-onset type 1 diabetes, but not with late-onset type 1 diabetes.

Authors:  Hye-Soon Lee; Hyewon Park; Seiwon Yang; Dukhee Kim; Yongsoo Park
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

8.  Evidence for association of an interleukin 23 receptor variant independent of the R381Q variant with rheumatoid arthritis.

Authors:  J E Hollis-Moffatt; M E Merriman; R A Rodger; K A Rowley; P T Chapman; N Dalbeth; P J Gow; A A Harrison; J Highton; P B B Jones; J L O'Donnell; L K Stamp; T R Merriman
Journal:  Ann Rheum Dis       Date:  2008-07-22       Impact factor: 19.103

9.  Association studies of the IL-23R gene in autoimmune thyroid disease in the Japanese population.

Authors:  Yoshiyuki Ban; Teruaki Tozaki; Matsuo Taniyama; Yasuko Nakano; Kei-Ichiro Yoneyama; Yoshio Ban; Tsutomu Hirano
Journal:  Autoimmunity       Date:  2009-02       Impact factor: 2.815

10.  Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation.

Authors:  Craig A Murphy; Claire L Langrish; Yi Chen; Wendy Blumenschein; Terrill McClanahan; Robert A Kastelein; Jonathon D Sedgwick; Daniel J Cua
Journal:  J Exp Med       Date:  2003-12-08       Impact factor: 14.307

View more
  7 in total

Review 1.  Interleukins and interleukin receptors in rheumatoid arthritis: Research, diagnostics and clinical implications.

Authors:  Lili Magyari; Dalma Varszegi; Erzsebet Kovesdi; Patricia Sarlos; Bernadett Farago; Andras Javorhazy; Katalin Sumegi; Zsolt Banfai; Bela Melegh
Journal:  World J Orthop       Date:  2014-09-18

2.  Preclinical development of AMG 139, a human antibody specifically targeting IL-23.

Authors:  K Köck; W J Pan; J M Gow; M J Horner; J P Gibbs; A Colbert; T J Goletz; K J Newhall; W A Rees; Y Sun; Y Zhang; J C O'Neill; A N Umble-Romero; S P Prokop; C D Krill; L Som; S A Buntich; M W Trimble; W H Tsuji; J E Towne
Journal:  Br J Pharmacol       Date:  2014-12-15       Impact factor: 8.739

3.  IL-17A, IL-17F and IL-23R Gene Polymorphisms in Polish Patients with Rheumatoid Arthritis.

Authors:  Katarzyna Bogunia-Kubik; Jerzy Świerkot; Anna Malak; Barbara Wysoczańska; Beata Nowak; Katarzyna Białowąs; Katarzyna Gębura; Lucyna Korman; Piotr Wiland
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2014-11-12       Impact factor: 4.291

4.  A multilocus genetic study in a cohort of Italian SLE patients confirms the association with STAT4 gene and describes a new association with HCP5 gene.

Authors:  Cinzia Ciccacci; Carlo Perricone; Fulvia Ceccarelli; Sara Rufini; Davide Di Fusco; Cristiano Alessandri; Francesca Romana Spinelli; Enrica Cipriano; Giuseppe Novelli; Guido Valesini; Paola Borgiani; Fabrizio Conti
Journal:  PLoS One       Date:  2014-11-04       Impact factor: 3.240

5.  IL23R single nucleotide polymorphisms could be either beneficial or harmful in ulcerative colitis.

Authors:  Sarah Fischer; Erzsébet Kövesdi; Lili Magyari; Veronika Csöngei; Kinga Hadzsiev; Béla Melegh; Péter Hegyi; Patrícia Sarlós
Journal:  World J Gastroenterol       Date:  2017-01-21       Impact factor: 5.742

6.  Circulating concentrations of interleukin (IL)-17 in patients with multiple sclerosis: Evaluation of the effects of gender, treatment, disease patterns and IL-23 receptor gene polymorphisms.

Authors:  Seyed Ali Ghaffari; Maryam Nemati; Hossain Hajghani; Hossainali Ebrahimi; Abdolkarim Sheikhi; Abdollah Jafarzadeh
Journal:  Iran J Neurol       Date:  2017-01-05

7.  Significant association between TAP2 polymorphisms and rheumatoid arthritis: a meta-analysis.

Authors:  Dongjun Dai; Yong Chen; Ping Ru; Xingyu Zhou; Jianmin Tao; Huadan Ye; Qingxiao Hong; Linlin Tang; Guanghui Pan; Danfeng Lin; Qiongyao Gong; Yuelong Lv; Leiting Xu; Shiwei Duan
Journal:  Diagn Pathol       Date:  2014-06-27       Impact factor: 2.644

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.